Change in the number of shares and votes in Meda

Meda has, in accordance with information previously announced, as part of the
agreed purchase price for Rottapharm S.p.A., completed an issue of 30,000,000
series A shares in favor of Rottapharm’s previous owners, Fidim S.r.l.

Prior to the issuance of new shares, the number of shares in Meda amounted to
302,243,065. Following the issue of new shares the total number of shares and
votes in Meda as of October 31, is 332,243,065 series A representing 332,243,065
votes.

For further inquiries, please contact:

Paula Treutiger, VP Corporate Communications &
Sustainability                                     ph: +46 733
-666 599


                                  paula.treutiger@meda.se

Meda AB discloses the information provided herein pursuant to the Securities
Markets Act and/or the Financial Instruments Trading Act. The information was
submitted for publication on October 31, 2014, at 08:00 CET.

MEDA AB (publ) is a leading international specialty pharma company. Meda’s
products are sold in more than 150 countries worldwide and the company is
represented by its own organizations in over 60 countries. The Meda share is
listed under Large Cap on Nasdaq Stockholm. Find out more, visit www.meda.se.